Evidence map›Paper›PMID 26219730›Full record

ArticleHeart and vessels2016

Efficacy of Endeavor zotarolimus-eluting stent implantation for the treatment of very late stent thrombosis with late-acquired incomplete stent apposition after sirolimus-eluting stent implantation.

Yuki Kakefuda, Akira Sato, Hiroaki Watabe, Hideaki Aihara, Hidetaka Nishina, Yuichi Noguchi, Tomoya Hoshi, Kazutaka Aonuma

Abstract readCase ReportsVideo-Audio Media
PubMed Publisher
In one paragraph

Article in Heart and vessels, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yuki KakefudaDepartment of Cardiology, Tsukuba Medical Center Hospital, Tsukuba, Japan.
Akira SatoDivision of Cardiovascular Medicine, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan. asato@md.tsukuba.ac.jp.
Hiroaki WatabeDepartment of Cardiology, Tsukuba Medical Center Hospital, Tsukuba, Japan.
Hideaki AiharaDepartment of Cardiology, Tsukuba Medical Center Hospital, Tsukuba, Japan.
Hidetaka NishinaDepartment of Cardiology, Tsukuba Medical Center Hospital, Tsukuba, Japan.
Yuichi NoguchiDepartment of Cardiology, Tsukuba Medical Center Hospital, Tsukuba, Japan.
Tomoya HoshiDivision of Cardiovascular Medicine, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.
Kazutaka AonumaDivision of Cardiovascular Medicine, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Very late stent thrombosis (VLST) is a serious complication after percutaneous coronary intervention. However, the best therapy for VLST with late-acquired incomplete stent apposition and incomplete neointimal coverage remains unknown. In these cases, neointimal coverage was nearly complete and no late-acquired malapposition was detected at 18 months after Endeavor zotarolimus-eluting stent (ZES) implantation for the treatment of VLST with late-acquired incomplete stent apposition after sirolimus-eluting stent implantation. We presented that Endeavor ZES implantation may become an attractive therapeutic strategy for the treatment of VLST with late-acquired incomplete stent apposition and incomplete neointimal coverage.

Indexed as

Drug-Eluting StentsAgedAngioplasty, BalloonCardiovascular AgentsCoronary AngiographyCoronary Artery DiseaseCoronary ThrombosisFemaleHumansMaleMiddle AgedNeointimaPercutaneous Coronary InterventionProsthesis DesignSirolimusThrombectomyCardiovascular AgentsSirolimuszotarolimusLate-acquired incomplete stent appositionSirolimus-eluting stentVery late stent thrombosisZotarolimus-eluting stent

Identifiers

PMID26219730

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.